Mercer Global Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Sell |
3,865
-121
| -3% | -$7.93K | ﹤0.01% | 1917 |
|
|
2025
Q1 | $281K | Sell |
3,986
-25
| -0.6% | -$1.76K | ﹤0.01% | 1795 |
|
|
2024
Q4 | $264K | Buy |
4,011
+21
| +0.5% | +$1.38K | ﹤0.01% | 1824 |
|
|
2024
Q3 | $281K | Buy |
3,990
+153
| +4% | +$10.8K | ﹤0.01% | 1647 |
|
|
2024
Q2 | $254K | Buy |
3,837
+266
| +7% | +$17.6K | ﹤0.01% | 1668 |
|
|
2024
Q1 | $242K | Buy |
+3,571
| New | +$242K | ﹤0.01% | 1682 |
|
|
2023
Q2 | – | Sell |
-4,419
| Closed | -$258K | – | 1979 |
|
|
2023
Q1 | $258K | Buy |
+4,419
| New | +$258K | ﹤0.01% | 1594 |
|